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Congestive heart failure (CHF) is a major cause of mortality and morbidity. Among patients with heart failure, sleep disordered
breathing (SDB) is a common problem. Current evidence suggests that SDB, particularly central SDB, is more prevalent in patients
with CHF than in the general population, but it is underdiagnosed as SDB symptoms that are less prevalent in CHF.Themain aims
of this study were to determine the relationship between nocturnal hypoxemia and left ventricular ejection fraction in patients with
chronic heart failure. Bymeans of echocardiography, 108 patientswith left ventricular ejection fraction≤45%were divided intomild,
moderate, and severe CHF. Hypoxemia was recorded overnight in the hospital and was measured by portable pulse oximetry. In
the 108 patients with CHF, 44 (40.7%) were severe, 17 (15.7%) moderate, and 47 (43.6%) mild CHF. 95 (88%) of patients with CHF
had abnormal patterns of nocturnal hypoxemia suggestive of Cheyne-Stokes respiration. Ejection fraction correlated negatively
with dip frequency. There was no correlation between nocturnal hypoxemia with BMI and snoring. This study confirms strong
associations between sleep apnea and heart disease in patients with CHF. Overnight oximetry is a useful screening test for Cheyne-
Stokes respiration in patients with known heart failure.
1. Introduction
Sleep related breathing disorders (SRBD) refer to an abnor-
mal respiratory pattern (e.g., apneas, hypopneas, or respira-
tory effort related arousals) or an abnormal reduction in gas
exchange (e.g., hypoventilation) during sleep. They tend to
repetitively alter sleep duration and architecture, resulting
in daytime symptoms, signs, or organ system dysfunction.
Sleep related breathing disorders are best characterized by
polysomnography that has captured one or more periods of
rapid eyemovement (REM) sleep, as severe perturbations can
be common during REM sleep [1, 2]. Sleep apnea is hypothe-
sized to increase the risk of developing cardiovascular disease
(CVD) and hypertension. Initial support for this hypothesis
came from several population studies of snoring and CVD
outcomes, suggesting that those who snore are more likely
to develop hypertension, myocardial infarction, and stroke
[3–5]. Two types of sleep disordered breathing are common
among patients with heart failure: obstructive sleep apnea
(OSA) and Cheyne-Stokes breathing (CSB).
1.1. Prevalence. While OSA is more common than CSB in the
general population, CSB may be more common than OSA in
patients with heart failure [6, 7]. Single-center observational
studies estimate that the prevalence of SRBD may be as high
as 50 percent among all patients with heart failure and as
high as 70 percent among patients with heart failure who
are referred to a sleep laboratory [6–9]. The prevalence may
be even higher among patients with acute decompensated
heart failure, as suggested by a study that detected an apnea
hypopnea index ≥10 events per hour of sleep in 22 out of 29
such patients (76 percent) [10].
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1.2. Risk Factors. Risk factors for SRBD in patients with
heart failure vary according to the type of SRBD. With
respect to CSB, risk factors include male gender, advanced
age, atrial fibrillation, and hypocapnia (i.e., transcutaneous
carbon dioxide ≤38mmHg) [9]. With respect to OSA, risk
factors include advanced age and an increasing body mass
index (BMI).
1.3. Pathogenesis. The pathogenesis of OSA involves abnor-
malities in pharyngeal anatomy, pharyngeal function, and
ventilatory control. In patients with heart failure, edema of
the upper airway is an additional factor that may contribute
to pharyngeal airway narrowing [11]. The pathogenesis of
CSB is uncertain, but the favored hypothesis is based on
the observation that patients who have heart failure and
CSB tend to have lower arterial carbon dioxide tensions
(PaCO
2
) than patients who have heart failure without CSB
[12, 13]. The net effect is oscillation of ventilation between
apnea and hyperpnea. Elimination of the hypocapnia with
inhaled CO
2
, continuous positive airway pressure (CPAP),
or oxygen can markedly attenuate CSB [14–17]. Both OSA
and CSB can impair systolic and diastolic cardiac function
by a variety of mechanisms. First, intermittent hypoxemia
and arousals induce adrenergic surges that may lead to
heart disease progression. Second, the extremely negative
intrapleural pressures increase ventricular transmural wall
stress and afterload [18].
1.4. Clinical Manifestations. A sleep history should be sought
from both the patient and the spouse because, in many
cases, it is only the spouse who is aware of the abnormal
ventilatory pattern. SRBD can be asymptomatic or symp-
tomatic in patients who have heart failure [19]. When OSA
is the predominant type of SRBD, poor sleep quality and
snoring are common. As a result, sleep disruption and easy
fatigability often exist and may be out of proportion to the
severity of the heart failure. However, sleepiness is relatively
uncommon in patients with heart failure for reasons that
remain unclear [20]. When CSB is the predominant type
of SRBD, symptoms due to CSB may be indistinguishable
from those due to the heart failure [6]. Symptoms of poor
sleep quality (e.g., excessive daytime sleepiness) are subtle
and generally unreliable. Occasionally, patients with CSB
report paroxysmal nocturnal dyspnea (due to the hyperpnea
that follows an apnea) [21]. SRBD may contribute to noc-
turnal angina in patients with heart failure, presumably due
to hypoxemia and catecholamine surges [21]. In addition,
recurrent arrhythmias may occur, such as atrial fibrillation or
ventricular tachycardia [9, 22].These arrhythmias often occur
in the absence of any symptoms or signs of SRBD. Thus, a
high index of suspicion should be maintained and evaluation
for SRBD should be considered in heart failure patients with
recurrent arrhythmias.
1.5. Diagnosis. The diagnostic evaluation of suspected SRBD
is the same for patients with or without heart failure. An in-
laboratory overnight polysomnogram is the gold standard
diagnostic test. In-homeportablemonitoring is also available.
The 2005 American College of Cardiology/American Heart
Association (ACC/AHA) guidelines on the diagnosis and
treatment of chronic heart failure indicate that screening for
SRBD is reasonable in selected patients (e.g., those with risk
factors) [23].
1.6. Prognosis. Heart failure accompanied by SRBD is associ-
ated with a worse prognosis than heart failure in the absence
of SRBD [24]. With respect to OSA, a prospective cohort
study followed up 164 patients who had heart failure and a
left ventricular ejection fraction of 45 percent or less [25].
At a mean of three years, patients who had OSA (defined as
an AHI of at least 15 events per hour) had a higher cardiac
mortality than patients who did not have OSA (8.7 versus
4.2 deaths per 100 patient-years). With respect to CSB, a
prospective cohort study followed up 62 patients with NYHA
class II to III heart failure [26]. At a mean of 28 months,
cardiac mortality was associated with an AHI greater than 30
events per hour. The AHI was a better predictor of cardiac
mortality than demographic variables, Holter monitoring,
exercise studies, echocardiography, or autonomic testing.
CSBwas found to predictmortality in numerous other studies
of patients with heart failure [7, 27–30].
1.7. Treatment. With respect to the impact of heart failure
therapy on SRBD, case series and observational studies
suggest that the following interventions are associated with
improved SRBD: medical management (e.g., ACE inhibitors,
beta blockers, and diuretics) [11, 25, 31, 32], cardiac trans-
plantation [33–35], cardiac resynchronization (i.e., biven-
tricular pacing) [36–38], and left ventricular assist device
(LVAD) implantation [39]. For patientswhohave heart failure
complicated by OSA or CSB, positive airway pressure may
improve cardiac function, blood pressure, exercise capacity,
and quality of life [15, 28, 40–46]. The possible role of
theophylline in patients with heart failure complicated by
SRBD was evaluated in a doubleblind crossover trial of 15
such patients who received either theophylline or placebo
twice daily for five days [47].
2. Materials and Methods
The current cross-sectional study is a descriptive, analyt-
ical one that was conducted on 108 patients referred to
the Imam Hospital from November 2010 to March 2011,
who had been hospitalized due to CHF. CHF diagnosis
was performed based on history, clinical examination, and
echocardiography. Given the prevalence of heart failure as
14% in Iran and considering that, in accordancewith previous
studies, approximately 51% of these patients suffer from sleep
disorders resulting from changes in arterial oxygen pressure,
the sample size for this study was estimated as 108 patients.
Inclusion criteria for this study included patients with systolic
CHF (congestive heart failure) (EF less than or equal to 45%)
and people with chronic obstructive pulmonary diseases
(COPD) and patients with unstable CHF were excluded.
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Table 1: Distribution of patients according to age and body mass
index.
Variable Number Minimum Maximum Mean SD
Age 108 35 86 65.42 11.40
BMI (Kg/m2) 108 20 38 26.93 3.74
Information on age, sex, BMI, and sleep patterns of
patients was obtained. Spirometric examinations were per-
formed on patients with CHF, and patients with COPD diag-
nosis based on medical history, physical examination, and
spirometry were excluded. Then, eligible patients underwent
pulse oximetry from the night until the next morning using
DC-68B (Shenzhen Creative Industry wrist oximeter).
In this study, the statistical software SPSSV16was used for
data analysis. The tests including chi-square, 𝑡-test, Pearson
correlation coefficient, and ANOVA were used for obtained
data analysis. The significance level was determined as less
than or equal to 0.05.
3. Results
In this study, 108 patients with stable chronic heart failure
were studied; 52 patients (48.1%) were males and 56 patients
(51.9%) were females.The patients’ age range was 35–86 years
with a mean of 65.42 ± 11 years, and the patients, BMI was
between 20 and 38 with a mean of 26.93 ± 3.74. 73 patients
(67.6%) had a BMI greater than or equal to 25 and 35 patients
(32.4%) had a BMI less than 25 (Table 1). Patients were
studied regarding sleep disorders. 62 patients (57.4%) were
snoring at night, and only 18 patients (16.7%) complained
of daytime sleepiness. The patients were classified regarding
ejection fraction into three groups, including mild failure
(ejection fraction between 40 and 45 percent), moderate
failure (ejection fraction between 35 and 40 percent), and
severe failure (less than or equal to 34 percent of ejection
fraction). The results showed that 47 patients (43.6%) had
mild heart failure; 17 patients (15.7%) had moderate heart
failure; and 44 patients (40.7%)were with severe heart failure.
The patients were also examined regarding the percentage
of their nocturnal sleep duration suffered from hypoxia. The
results showed that 42.6% of patients experienced hypoxia in
10% of their total nocturnal recording time; 9.1% of patients
had suffered from hypoxia in 40–70% of their total nocturnal
recording time; 5.4% of patients had hypoxia in more than
75% of their total nocturnal recording time; and in 12%
of patients, hypoxia was not observed in total nocturnal
recording time. During evaluating the patients about daily
hypoxia (during waking hours), the results showed that only
6.5% of the patients experience arterial oxygen desaturation
at the time of awakening.
Patients with different levels of ejection fraction and with
different levels of arterial oxygen desaturationwere compared
(Table 2). The results showed that patients with mild heart
failure in the majority of arterial blood oxygen saturation
levels had the least hypoxia time; however, the analysis
of variance showed no significant difference between the
three groups of patients. Thus, Pearson correlation test was
also performed to investigate the relationship between levels
of arterial oxygen desaturation and ejection fraction. The
results showed that, at levels of arterial oxygen desaturation
between 80–84%, 75–79%, and 65–69%, there is a significant
correlation between the two variables of arterial oxygen
saturation percentage and ejection fraction, so that with
decrease in ejection fraction, the arterial oxygen desaturation
in patients increases.
The arterial oxygen desaturation was also calculated
according to patients’ gender.The results showed that arterial
oxygen desaturation rate in women is higher than in men;
however, performing 𝑡-test showed no statistically significant
differences between the two groups (𝑃 = 0.43). The
correlation test was also performed between arterial oxygen
desaturation and the age of patients; however, no significant
correlationwas found between these two variables (𝑃 = 0.07).
Arterial oxygen desaturation in patients with complaints
of sleep disorders and without sleep disorders was examined.
The results showed that the decline in arterial oxygen satura-
tion is higher in patients with nocturnal snoring than patients
without snoring at night; however, performing independent
𝑡-test showed no significant differences between the two
groups (𝑃 = 0.90). The mean arterial oxygen desaturation
rate was also compared in two groups of patients with BMI
greater than or equal to 25 and less than 25. The results
showed that patients with a BMI greater than or equal to 25
have a greater mean arterial oxygen desaturation rate than
patients with lower BMI; however, the independent 𝑡-test
showed no significant differences between the two groups
(𝑃 = 0.72).
4. Discussion
Heart failure (HF) is amajor cause ofmortality andmorbidity
[48] and is associated with progressively severe symptoms,
chronic disability, and impaired quality of life [6]. Sleep-
disordered breathing (SDB) is known to occur frequently in
patients with stable but severe HF [6, 19, 48] and may be
a predictor of poor prognosis [29]. Sleep related breathing
disorders (SRBD) appear to be common even among patients
whose heart failure is optimally managed. SDB is present in
approximately three-fourths of patients with symptomatic or
decompensated systolic heart failure [45, 46].The prevalence
is very high even in those with stable chronic heart failure
[6, 47, 48]. Cross-sectional analyses from Sleep Heart Health
Study data revealed an adjusted odds ratio of 2.2 for self-
reported heart failure amongst subjects with OSA.
In this study, 88% of patients with heart failure expe-
rienced SRBD during their total nocturnal recording time.
In a study by Javaheri et al. in 1998, 51% of male patients
with stable heart failure had SRBD, 40% of which was central
sleep apnea type (CSA) and 11% was obstructive sleep apnea
type (OSA) [6]. In another study in China by Wang et al.
conducted on 195 patients with heart failure, the SRBD was
seen in 80%of patients, 53%ofOSA type and 27%ofCSA type
[49]. In a study by Rao et al. performed in 2006 in the United
Kingdom, the SRBD prevalence was reported on average as
24% [50]. In a study by Lanfranchi et al., the SRBDwas found
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Table 2: Correlation between the two variables of arterial oxygen saturation percentage and ejection fraction in study patients.
Arterial oxygen
saturation percentage Mild CHF (mean ± SD) Moderate CHF (mean ± SD) Severe CHF (mean ± SD) 𝑃 value
60–65% 0.17 ± 0.41 0.11 ± 0.25 0.34 ± 0.65 0.16
65–70% 0.22 ± 0.58 0.11 ± 0.20 0.32 ± 0.47 0.31
70–75% 0.68 ± 1.75 1.73 ± 6.51 0.81 ± 1.13 0.42
75–80% 1.84 ± 6.09 3.85 ± 11.26 2.57 ± 3.69 0.57
80–85% 3.90 ± 8.11 7.23 ± 12.17 5.84 ± 8.75 0.36
85–89% 12.77 ± 15.52 14.02 ± 16.67 16.04 ± 18.40 0.65
in 55% of patients with asymptomatic heart failure with LVEF
less than 40% [19, 26]; but in a study by Tremel et al., 82%
of patients with heart failure had SRBD [51]. A prospective
cohort study followed up 108 patients who visited a heart
failure clinic with stable heart failure, which was defined
as clinical stability without hospitalizations or medication
changes within the past 30 days [52]. SRBD was detected in
61 percent of patients and was independently associated with
the presence of atrial fibrillation and a worse New York Heart
Association (NYHA) functional class.
In the present study, no significant relationship was found
between age and arterial oxygen desaturation. In a study
by Staniforth et al. in 1998 performed on 104 patients, no
significant relationship was found between age and arterial
oxygen saturation. In this study, the nocturnal pulse oximetry
was identified as a useful screening test for Cheyne-Stokes
respiration in patients with heart failure [53]. However, in a
study by Sin et al. to evaluate risk factors of CSA and OSA
performed on 450 patients with heart failure, the patients
with CSA were older than patients with OSA [9]. In a
study by Liu et al. in 2006 on 56 elderly patients with CHF,
67.9% of patients had SRBD and the OSA prevalence was
higher in older patients [54]. Male gender may be a risk
factor for CSA because, in general, men have a less stable
sleep architecture than women, with a greater number of
sleep-wake transitions and shorter slow-wave sleep, which
may predispose to respiratory control system instability and
central apneas [55].
In our study, patients with a BMI greater than 25 had
a mean arterial oxygen desaturation higher than patients
with a lower BMI; however, no statistically significant dif-
ference was found between the two groups. Considering
that polysomnography was not available in our study and
evaluation of arterial oxygen desaturation was performed by
using a portable pulse oximetry, there was no possibility to
differentiate patients with OSA from CSA. However, since
the prevalence of CSA in patients with cardiac failure is
more than OSA, we expect that most of our patients have
CSA, and the lack of significant correlation between BMI and
arterial oxygen desaturation can be explained in this regard.
In Javaheri et al.’s study, high BMI was more common only
in patients with OSA [6]. In Sin et al.’s study, high BMI was
significantly correlated with OSA. In this study, high BMI
association with OSA, which was more in men, was due to
android pattern of obesity in them [9].
In the present study, snoring at night (nocturnal snoring)
was seen in 57.4% of patients. In heart failure patients who
had nocturnal snoring, themean arterial oxygen desaturation
was more than in patients without this clinical symptom; but
there was no statistically significant difference between the
two groups. In Javaheri et al.’s study, 78% of patients withOSA
had nocturnal snoring, and only 28% of patients with CSA
had nightly snoring [6].
In our study, daytime sleepiness was seen in only 16.7% of
the patients. In Wang et al.’s study, patients with heart failure
who had SRBDwere not mentioning daytime sleepiness [49].
The first goal in the treatment of SDB in CHF is to optimize
CHF treatment. Conservative measures for OSA such as
weight reduction, avoidance of supine position during sleep,
and avoiding alcohol and sedative medications before sleep
are also useful. Nocturnal CPAP therapy may be useful in
treating SDB in CHF [56].
In the present study, there was a significant correlation
between the severity of arterial oxygen desaturation rate
and ejection fraction. In similar studies by Staniforth et al.
[53], Javaheri et al. [6], and Shahar et al. [57], a significant
correlation between decreased ejection fraction and arterial
oxygen desaturation was seen.
5. Conclusion
Several studies in recent years have demonstrated the
close relationship between sleep related breathing disorders
(SRBD) and systolic heart failure. In the present study, 88%
of patients with heart failure experienced SRBD during their
total nocturnal recording time. Unfortunately, in clinical
treatment of systolic heart failure, SRBD is hardly considered.
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